Comorbid Vulvar Lichen Sclerosus and High-Grade Squamous Intraepithelial Lesions: A Management Conundrum
Authors:
- 13 August 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 26 (4) , 319-322
Abstract
Objective: This study aimed to determine if treating lichen sclerosus (LS) with high-potency topical corticosteroids (TCS) increases the risk of high-grade squamous intraepithelial lesion (HSIL) recurrence in patients with comorbid vulvar LS and HSIL. Methods: This is a retrospective study of patients with comorbid vulvar LS and HSIL treated with TCS between 2015 and 2020. Patients with clinically diagnosed or biopsy-proven LS and biopsy-proven HSIL of the vulva were included. Clinical data included demographics, tobacco use, immune-modifying conditions, specimen pathology, treatment types, and HSIL recurrence. Bivariate analysis was performed to compare demographic and clinical characteristics between patients with and without HSIL recurrence. Results: Twenty-six patients with comorbid LS and HSIL were identified. The median age was 66.0 years and median time in treatment for LS was 5.5 years. Thirteen (50%) had recurrence of HSIL and 13 (50%) did not have recurrence. Exposure to high-potency TCS was present in 20 (77%) patients, with 17 (65%) having use of more than 1-year duration and 9 (35%) having use at the time of HSIL diagnosis. When comparing the groups with and without HSIL recurrence, there was no significant difference in high-potency TCS exposure, duration of use, or use at time of HSIL diagnosis. Conclusions: High-potency TCS use for the treatment of LS did not seem to increase the risk of HSIL recurrence in patients with comorbid vulvar LS and HSIL. This suggests that high-potency TCS can be appropriately used for the treatment of LS even when HPV-associated disease is present.Keywords
This publication has 21 references indexed in Scilit:
- Differentiated Vulvar Intraepithelial Neoplasia-like and Lichen Sclerosus-like Lesions in HPV-associated Squamous Cell Carcinomas of the VulvaAmerican Journal of Surgical Pathology, 2018
- Vulvar intraepithelial neoplasia: Risk factors for recurrenceGynecologic Oncology, 2018
- HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is Associated With an Aggressive Clinical CourseInternational Journal of Gynecological Pathology, 2017
- The Natural History of Vulvar Intraepithelial Neoplasia, Differentiated Type: Evidence for Progression and Diagnostic ChallengesInternational Journal of Gynecological Pathology, 2016
- Long-term Management of Adult Vulvar Lichen SclerosusJAMA Dermatology, 2015
- Vulvar intraepithelial neoplasia (VIN 2/3): Comparing clinical outcomes and evaluating risk factors for recurrenceGynecologic Oncology, 2012
- Consequences of systemic absorption of topical glucocorticoidsJournal of the American Academy of Dermatology, 2011
- Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trialGynecologic Oncology, 2011
- The effect of vulvar lichen sclerosus on quality of life and sexual functioningJournal of Psychosomatic Obstetrics & Gynecology, 2010
- Vulvar Squamous Cell Carcinoma is a Multifactorial Disease Following Two Separate and Independent PathwaysInternational Journal of Gynecological Pathology, 2006